bioRASI

The Translational

Clinical Development CRO

bioRASI routinely implements efficient and flexible clinical development strategies, solutions, and services including program management, clinical operations, regulatory affairs, compliance and audit, biostatistics, data management, and more.

 

bioRASI focuses on the entire range of Phase I and Phase II trials for innovative products as well as on clinical endpoint and bioequivalence trials for ANDA and 505b2.

From IND through PHASE II… for Innovative Therapeutics

 

From Pilot through Pivotal … for Generics and 505(b)(2)

Home

About Us

Our Services

News & Events

Contact Us

bioRASI, LLC    |     3440 Hollywood Blvd. Suite 100     |      Hollywood, FL 33021     |     T-786.388.0700  F-786.388.6044     |     info@biorasi.com

bioRASI is a Full Service Global CRO that collaborates with the leading biotech and pharmaceutical companies in designing and implementing successful clinical trials.  

 

In carrying out both Innovative and Generic Programs, bioRASI leverages its full service capabilities and global resources to achieve unparalleled scientific, clinical and business outcomes for its sponsors.